GlobalRPh RX List - Gleolan
- Product / population
- Oral GLEOLAN fluorescence-guided glioma imaging; selected renal pharmacokinetic uncertainty.
- Renal measure
- Renal impairment; no validated dose-adjustment threshold supplied.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
Renal elimination contributes to clearance, and impairment may reduce elimination. The source states that the need for dose adjustment is unknown. Do not equate the absence of an adjustment table with proof that the standard exposure is safe across severe impairment or dialysis. This is an explicit renal evidence gap in a surgical-imaging product, not a chronic dosing protocol.